Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ALBIREO PHARMA, INC. | y80991e10vk.htm |
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | y80991exv21w1.htm |
| EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | y80991exv23w1.htm |
| EX-10.20 - EX-10.20 - ALBIREO PHARMA, INC. | y80991exv10w20.htm |
| EX-10.22 - EX-10.22 - ALBIREO PHARMA, INC. | y80991exv10w22.htm |
| EX-31.02 - EX-31.02 - ALBIREO PHARMA, INC. | y80991exv31w02.htm |
| EX-10.19 - EX-10.19 - ALBIREO PHARMA, INC. | y80991exv10w19.htm |
| EX-31.01 - EX-31.01 - ALBIREO PHARMA, INC. | y80991exv31w01.htm |
Exhibit 32.01
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Biodel Inc. (the “ Company ”) for
the year ended September 30, 2009 as filed with the Securities and Exchange Commission on the date
hereof (the “ Report ”), the undersigned Solomon S. Steiner, President and Chief Executive
Officer of the Company and Gerard Michel, Chief Financial Officer, Vice President Corporate
Development and Treasurer of the Company, each hereby certifies that: (1) the Report fully complies
with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended;
and (2) the information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
/s/ Solomon S. Steiner
|
||
Chairman, President and |
||
Chief Executive Officer |
||
Dated: December 14, 2009 |
||
/s/ Gerard Michel
|
||
Chief Financial Officer, |
||
Vice President, Corporate |
||
Development and Treasurer |
Dated: December 14, 2009